Answers are grounded in this paper and cite their sources.
Reveals links between antiphospholipid antibodies and reproductive failure, highlighting improved outcomes with heparin therapy during pregnancy.
The relationship between antiphospholipid antibodies and the clinical features of placental insufficiency, pre-eclampsia, and fetal loss has emerged as one of the most exciting new observations in obstetrics in the last 15 years. Antiphospholipid syndrome is the only convincing ‘immunologic’ disturbance of pregnancy affecting the fetus other than anti-erythrocyte or antiplatelet alloimmunization disorders, and it is now routine to test patients with fetal loss for the two best characterized antiphospholipid antibodies, lupus anticoagulant and anticardiolipin. Although there is no proven mechanism for fetal loss, treatment of antiphospholipid antibody-positive mothers during pregnancy with heparin improves pregnancy outcome.
No takes yet. Share an insight, caveat, or question.
Branch et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: